The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Theriva Biologics Inc (AMEX: TOVX) closed the day trading at $0.46 down -1.88% from the previous closing price of $0.46. In other words, the price has decreased by -$1.88 from its previous closing price. On the day, 0.15 million shares were traded. TOVX stock price reached its highest trading level at $0.4571 during the session, while it also had its lowest trading level at $0.4354.
Ratios:
For a better understanding of TOVX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 3725080 and an Enterprise Value of -3433920.
Stock Price History:
The Beta on a monthly basis for TOVX is 0.92, which has changed by -0.93185186 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $10.75, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is -57.47%, while the 200-Day Moving Average is calculated to be -74.95%.
Shares Statistics:
Over the past 3-months, TOVX traded about 883.28K shares per day on average, while over the past 10 days, TOVX traded about 526120 shares per day. A total of 8.19M shares are outstanding, with a floating share count of 8.10M. Insiders hold about 1.04% of the company’s shares, while institutions hold 2.33% stake in the company. Shares short for TOVX as of 1745971200 were 73952 with a Short Ratio of 0.08, compared to 1743379200 on 79024. Therefore, it implies a Short% of Shares Outstanding of 73952 and a Short% of Float of 2.6700001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
